0.7713
-0.0502
(-6.11%)
At close: April 8 at 4:00:02 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 2 | 2 | 2 |
| Avg. Estimate | -0.15 | -0.29 | -1.19 | -1.08 |
| Low Estimate | -0.15 | -0.31 | -1.22 | -1.15 |
| High Estimate | -0.15 | -0.27 | -1.16 | -1.01 |
| Year Ago EPS | -0.32 | -0.14 | -0.75 | -1.19 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 4 | 4 | 4 |
| Avg. Estimate | 59.79M | 12.38M | 103.15M | 98.8M |
| Low Estimate | 52.36M | 10M | 95M | 64.76M |
| High Estimate | 72M | 15.6M | 109.03M | 158.78M |
| Year Ago Sales | 77.06M | 64.98M | 266.96M | 103.15M |
| Sales Growth (year/est) | -22.42% | -80.95% | -61.36% | -4.22% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.26 | -0.11 | -0.13 |
| EPS Actual | -0.32 | -0.14 | -0.01 | -0.28 |
| Difference | -0.11 | 0.12 | 0.1 | -0.15 |
| Surprise % | -52.74% | 45.21% | 90.48% | -114.63% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.29 | -1.19 | -1.08 |
| 7 Days Ago | -0.06 | -0.02 | -0.01 | -1.08 |
| 30 Days Ago | -0.06 | -0.02 | -0.01 | 0.16 |
| 60 Days Ago | -0.06 | 0 | 0.01 | 0.16 |
| 90 Days Ago | -0.06 | 0 | 0.01 | 0.16 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CHRS | 53.13% | -107.14% | -58.67% | 9.24% |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
| Maintains | Baird: Outperform to Outperform | 12/5/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/4/2024 |
| Maintains | Baird: Outperform to Outperform | 11/8/2024 |
Related Tickers
ATRA Atara Biotherapeutics, Inc.
5.59
-2.44%
HEPA Hepion Pharmaceuticals, Inc.
0.4100
-6.82%
KPTI Karyopharm Therapeutics Inc.
3.9600
-1.98%
ALLR Allarity Therapeutics, Inc.
0.7511
-5.62%
FBIO Fortress Biotech, Inc.
1.4300
-2.72%
GOSS Gossamer Bio, Inc.
0.7880
-3.97%
CTMX CytomX Therapeutics, Inc.
0.4551
+5.47%
ALDX Aldeyra Therapeutics, Inc.
1.9200
-1.54%
FATE Fate Therapeutics, Inc.
0.9058
-0.40%
SGMO Sangamo Therapeutics, Inc.
0.6278
-11.19%